Cutler; Neal R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cutler; Neal R..The latest application filed is for "compositions and methods for the administration clozapine formulations which modulate body weight".

Company Profile

0.9.18

Cutler; Neal R. - Beverly Hills CA
Cutler; Neal R. - Los Angeles CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the administration clozapine formulations which modulate body weight App 20070093471 - Cutler; Neal R.	2007-04-26
Compositions and methods for the administration psychotropic drugs which modulate body weight App 20070092586 - Cutler; Neal R.	2007-04-26
Use of monochloroflosequinan in the treatment of sexual dysfunction Grant 7,041,677 - Cutler May 9, 2	2006-05-09
Methods for the treatment of central nervous system disorders in certain patient groups Grant 6,995,173 - Cutler , et al. February 7, 2	2006-02-07
Compositions and methods for the co-formulation and administration of tramadol and propoxyphene App 20050089558 - Cutler, Neal R.	2005-04-28
Treatment of cardiovascular disease with quinolinone enantiomers App 20050009866 - Cutler, Neal R. ; et al.	2005-01-13
Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine App 20040191178 - Cutler, Neal R.	2004-09-30
Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine Grant 6,685,951 - Cutler February 3, 2	2004-02-03
Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine App 20030198669 - Cutler, Neal R. ; et al.	2003-10-23
Use of halogenated heterocyclic compounds in the treatment of sexual dysfunction and cardiovascular disease App 20030191152 - Cutler, Neal R.	2003-10-09
Methods for the treatment of central nervous system disorders in certain patient groups App 20030130311 - Cutler, Neal R. ; et al.	2003-07-10
Treatment of sexual dysfunction in certain patient groups App 20030105128 - Cutler, Neal R.	2003-06-05
Sustained release topiramate App 20030072802 - Cutler, Neal R.	2003-04-17
Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine App 20030022910 - Cutler, Neal R.	2003-01-30
Sublingual administration of dihydroergotamine for the treatment of migraine App 20030017175 - Cutler, Neal R.	2003-01-23
Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine App 20030017994 - Cutler, Neal R.	2003-01-23
Sublingual administration of dihydroergotamine for the treatment of migraine App 20030008005 - Cutler, Neal R.	2003-01-09
The treatment of sexual dysfunction with enantiomers App 20020147217 - Cutler, Neal R. ; et al.	2002-10-10
Methods For The Treatment Of Central Nervous System Disorders In Certain Patient Groups App 20020147215 - Cutler, Neal R. ; et al.	2002-10-10
Treatment Of Gastroparesis In Certain Patient Groups App 20020143030 - Cutler, Neal R. ; et al.	2002-10-03
Treatment of cardiovascular disease with quinolinone enantiomers App 20020143031 - Cutler, Neal R. ; et al.	2002-10-03
Treatment of gastroparesis in certain patient groups Grant 6,451,813 - Cutler , et al. September 17, 2	2002-09-17
Treatment of sexual dysfunction in certain patient groups Grant 6,258,373 - Cutler July 10, 2	2001-07-10
Treatment of sexual dysfunction in certain patient groups Grant 6,132,753 - Cutler October 17, 2	2000-10-17
Use of quinolines and quinolones to treat male erectile dysfunction Grant 6,110,489 - Cutler August 29, 2	2000-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.